6978.HK
Price:
$2.85
Market Cap:
$1.32B
Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. Its core product is EAL, a multi-target cellular immunotherapy product that is in Phase II clinical trials for the prevention of postsurgical recurrence of liver cancer. The company is also conducting pre-clinical and clinical trial studies for EAL to treat lung cancer, glioma, gastric cancer, and colorectal cancer. In addition, it develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute lymph...[Read more]
Industry
Biotechnology
IPO Date
2020-07-10
Stock Exchange
HKSE
Ticker
6978.HK
According to Immunotech Biopharm Ltd’s latest financial reports and current stock price. The company's current ROE is 287.10%. This represents a change of 104.50% compared to the average of 140.39% of the last 4 quarters.
The mean historical ROE of Immunotech Biopharm Ltd over the last ten years is 141.08%. The current 287.10% ROE has changed 103.49% with respect to the historical average. Over the past ten years (40 quarters), 6978.HK's ROE was at its highest in in the December 2024 quarter at 709.97%. The ROE was at its lowest in in the June 2020 quarter at -248.44%.
Average
141.08%
Median
-43.08%
Minimum
-192.85%
Maximum
1.41%
Discovering the peaks and valleys of Immunotech Biopharm Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 298.55%
Maximum Annual ROE = 1.41%
Minimum Annual Increase = -828.95%
Minimum Annual ROE = -192.85%
| Year | ROE | Change |
|---|---|---|
| 2024 | 1.41% | -828.95% |
| 2023 | -192.85% | 208.23% |
| 2022 | -62.57% | 45.23% |
| 2021 | -43.08% | 10.63% |
| 2020 | -38.94% | -39.68% |
| 2019 | -64.55% | 298.55% |
The current ROE of Immunotech Biopharm Ltd (6978.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
383.45%
5-year avg
213.67%
10-year avg
141.08%
Immunotech Biopharm Ltd’s ROE is greater than 3D Medicines Inc. (-22.45%), greater than Zhaoke Ophthalmology Limited (-15.44%), greater than JW (Cayman) Therapeutics Co. Ltd (-59.45%), greater than Genor Biopharma Holdings Limited (1.79%), greater than Transcenta Holding Limited (-37.95%), greater than Brii Biosciences Limited (-14.61%), greater than Wuhan YZY Biopharma Co Ltd (-5050.94%), greater than SinoMab BioScience Limited (-66.18%), less than Sirnaomics Ltd. (412.36%), greater than Sunho Biologics, Inc. (-16.53%),
| Company | ROE | Market cap |
|---|---|---|
| -22.45% | $1.16B | |
| -15.44% | $1.53B | |
| -59.45% | $1.13B | |
| 1.79% | $1.63B | |
| -37.95% | $930.12M | |
| -14.61% | $1.05B | |
| -5050.94% | $1.37B | |
| -66.18% | $1.77B | |
| 412.36% | $819.43M | |
| -16.53% | $1.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunotech Biopharm Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Immunotech Biopharm Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Immunotech Biopharm Ltd's ROE?
How is the ROE calculated for Immunotech Biopharm Ltd (6978.HK)?
What is the highest ROE for Immunotech Biopharm Ltd (6978.HK)?
What is the 3-year average ROE for Immunotech Biopharm Ltd (6978.HK)?
What is the 5-year average ROE for Immunotech Biopharm Ltd (6978.HK)?
How does the current ROE for Immunotech Biopharm Ltd (6978.HK) compare to its historical average?